Shanghai Benemae Pharmaceutical Corp. engages in the research, development, and distribution of biopharmaceuticals in the fields of endocrinology, cardiology, and oncology. Its products include diabetes medicine, obesity treatment products, fatty liver medication, and hepatitis treatment products. The company was founded on January 12, 1999 and is headquartered in Shanghai, China.